RxDoctor Payments DataLook up a doctor →

Kirk Bowden, DO

Pain Medicine · Mesa, AZNPI 1255592994

Payments from drug & device makers

$51,059in general payments, 2019–2025

Across 717 payments — averaging $71.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$19K
  • Boston Scientific$9K
  • Abbott$7K
  • Tersera Therapeutics LLC$7K
  • Spinal Simplicity, LLC$2K
  • Vertiflex, Inc.$1K
  • plus $6K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)78$19,250
Boston Scientific229$9,373
Abbott36$6,846
Tersera Therapeutics LLC40$6,740
Spinal Simplicity, LLC4$1,623
Vertiflex, Inc.7$1,307
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC38$563
Nevro Corp.15$520
Saluda Medical Americas, Inc.21$500
Collegium Pharmaceutical, Inc.39$466
AbbVie(2 entities)23$454
Nalu Medical, Inc.14$306
Biotronik NRO, Inc.11$271
Relievant Medsystems, Inc.5$229
Protega Pharmaceutials Inc4$225
Daiichi Sankyo Inc.21$164
Scilex Pharmaceuticals Inc.10$159
Arbor Pharmaceuticals, Inc.15$153
SPR Therapeutics, Inc8$152
Stryker3$145
GRT US Holding, Inc.7$114
Averitas Pharma Inc.4$101
Novartis5$92
Teva Pharmaceuticals USA, Inc.5$88
West Therapeutics Development, LLC4$77
Saol Therapeutics Inc.1$77
Amgen3$73
Zyla Life Sciences, Inc.7$72
Zavation Medical Products, LLC3$71
Biodelivery Sciences International, Inc.4$66
Assertio Therapeutics, Inc.7$59
Lilly USA, LLC4$55
AstraZeneca4$47
Redhill Biopharma Inc.3$44
Shionogi Inc3$42
Pfizer2$40
Ferring Pharmaceuticals Inc.2$30
Azurity Pharmaceuticals, Inc.2$29
Johnson & Johnson(2 entities)2$29
Foundation Fusion Solutions, LLC2$28
Painteq LLC1$27
Convatec Inc.1$24
Bioventus LLC1$23
MML US, Inc.1$22
Stratus Medical, LLC2$21
Springworks Therapeutics, Inc.1$21
Pacira Pharmaceuticals Incorporated1$20
Orthogenrx Inc.1$20
Vertos Medical, Inc.1$20
Hikma Pharmaceuticals USA1$19
Fidia Pharma USA Inc.1$18
Tonix Medicines, Inc.1$18
Merz Pharmaceuticals, LLC1$17
Avanos Medical1$17
Vertex1$16
International Rehabilitative Sciences, Inc1$15
Biohaven Pharmaceuticals, Inc.1$15
Piramal Critical Care1$14
Sentynl Therapeutics, Inc.1$14
Forte Bio-pharma LLC1$12

How this compares

$51,059 in reported general payments places this provider in the 90th percentile of 180 pain medicine providers in Arizona.

See all pain medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$528,387
Medicare patients
750
Services billed
2,853

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pain medicine in Mesa

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →